End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
83 TWD | -0.60% | 0.00% | +3.11% |
07/03 | CH Biotech R&D Co., Ltd.(TWSE:6534) added to Taiwan TAIEX Index | CI |
29/02 | CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 1.62B 50.07M 4.18B | Sales 2025 * | - | Capitalization | 8.53B 264M 22.06B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 5.28 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
1 day | -0.60% | ||
Current month | -0.12% | ||
1 month | -2.58% | ||
3 months | +1.72% | ||
6 months | +1.22% | ||
Current year | +3.11% |
Managers | Title | Age | Since |
---|---|---|---|
Cho Chun Huang
CEO | Chief Executive Officer | - | 01/21/01 |
Cheng Pang Wu
FOU | Founder | - | 29/13/29 |
Xiu Feng Lin
DFI | Director of Finance/CFO | - | 26/17/26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chien Chung Kuo
BRD | Director/Board Member | - | 10/15/10 |
Brent Smith
BRD | Director/Board Member | - | 15/14/15 |
Cheng Pang Wu
FOU | Founder | - | 29/13/29 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 83 | -0.60% | 34,000 |
02/24/02 | 83.5 | +0.48% | 17,150 |
30/24/30 | 83.1 | +0.73% | 37,150 |
29/24/29 | 82.5 | -0.60% | 23,941 |
26/24/26 | 83 | 0.00% | 64,000 |
End-of-day quote Taiwan S.E., May 03, 2024
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.11% | 264M | |
+19.30% | 39.89B | |
-.--% | 11.22B | |
-1.90% | 7.72B | |
+2.38% | 6.54B | |
-5.50% | 5.97B | |
-4.27% | 5.7B | |
-11.80% | 5.52B | |
+29.81% | 5.13B | |
-15.99% | 4.44B |
- Stock Market
- Equities
- 6534 Stock